Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma (Q33362194)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma |
scientific article |
Statements
1 reference
Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma (English)
1 reference
S Rao
1 reference
D Watkins
1 reference
D Dunlop
1 reference
P Selby
1 reference
B W Hancock
1 reference
C Fegan
1 reference
D Culligan
1 reference
S Schey
1 reference
T C M Morris
1 reference
T Lissitchkov
1 reference
J W Oliver
1 reference
J T Holmlund
1 reference
1 September 2004
1 reference
1 reference
Identifiers
1 reference